MEK inhibitors for the treatment of non-small cell lung cancer

Overview of attention for article published in Journal of Hematology & Oncology, January 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 3 news outlets
twitter: 2 X users

patent: 1 patent

Citations

dimensions_citation: 162 Dimensions

Readers on

mendeley: 139 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 4 news stories from 3 outlets.

Predicting drug response from single-cell expression profiles of tumours | BMC Medicine

Health Reporter, 01 Dec 2023

Ocular Toxicities of MEK Inhibitors in Patients With Cancer: A Systematic Review and Meta-analysis

Cancer Network, 24 Mar 2023

Jing Han, MD, and colleagues examine the prevalence and characteristics of ocular toxicities associated with MEK inhibition.

Lung cancer: New drug combination reduces tumors in animal study

Medical News Today, 21 Mar 2023

Lung cancer is the second most common form of cancer worldwide. Each year, around 2 million people receive a lung cancer…

What to know about stem cell therapy and non-small cell lung cancer

Medical News Today, 13 Oct 2021

Experts are looking at the potential of stem cell therapy in developing new therapies aimed at conditions that do not respond…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.